– UK, London – RSA Insurance Group plc (LSE:RSA), today announces the appointment of Charlotte Jones as a Non-Executive Board Director effective on 1 April 2018. Charlotte will join the Group Audit and Board Risk Committees.
Charlotte is currently Chief Financial Officer and Executive Director at Jupiter Fund Management plc.
Charlotte has significant FS, financial and accounting expertise. In addition to her FTSE 250 board experience as an executive director of Jupiter Fund Management, she has held a number of senior finance roles within Credit Suisse and Deutsche Bank and was a partner in Ernst & Young’s financial services practice.
Charlotte brings a wide range of commercial, investment, finance, risk management, regulatory and capital experience from the banking and asset management sectors.
Commenting on the appointment, RSA Chairman Martin Scicluna said: “I am delighted to welcome Charlotte to RSA’s Board. She brings significant financial services and technical financial and accounting expertise which will complement well the existing expertise of the Board. We look forward to leveraging Charlotte’s commercial and finance experience and knowledge to help ensure that RSA continues to deliver value for its customers and shareholders.”
With a 300 year heritage, RSA is one of the world’s leading multinational quoted insurance groups. Focusing on general insurance, RSA’s core markets are the UK and Ireland, Scandinavia and Canada with the capability to write business across the globe. We have around 12,600 employees across the core businesses and, in 2017, our net written premiums were £6.7 billion.
For more information : http://www.rsagroup.com
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.